Medicina de Familia-SEMERGEN最新文献

{"title":"Protocolo para el manejo de la apnea obstructiva de sueño con cribado mediante el cuestionario STOP-Bang y métodos simplificados de diagnóstico por Atención Primaria en la comarca de Osona, Cataluña central (Barcelona)","authors":"C. Muñoz-Pindado ,&nbsp;R. Bonich-Juan ,&nbsp;M. Deutú-Colom ,&nbsp;P.M. Martínez-Molina ,&nbsp;L. Escabias-Santamarta ,&nbsp;X. Bartrina-Alabau ,&nbsp;J. Serra-Batlles ,&nbsp;F. Ruiz-Mori ,&nbsp;S. Balmes-Estrada ,&nbsp;C. Serra ,&nbsp;A.M. Muñoz-Fernández ,&nbsp;C. Embid ,&nbsp;M. Dalmases ,&nbsp;I. Casademunt-Codina ,&nbsp;N. Roger-Casals","doi":"10.1016/j.semerg.2024.102398","DOIUrl":"10.1016/j.semerg.2024.102398","url":null,"abstract":"<div><div>Obstructive Sleep Apnea (OSA) is a widespread disease, but usually is an underdiagnosed and undertreated public health problem. Nowadays its study is expensive. Collaboration and involvement of all specialties are necessary, also the implementation of simplified diagnostic methods to try to improve detection, increase the diagnosis and treatment ratio.</div><div>In the Osona region (Barcelona), it has been developed a protocol that defines a new care process that shortens and reduces the cost of the OSA's diagnosis process. This new care process also favors better knowledge of the pathology of OSA by all the specialists involved, resulting in an increase in community health, in addition to generating knowledge.</div><div>This new care process could be implemented in other health areas around all the country and it would improve the management of this pathology and improve national community health.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102398"},"PeriodicalIF":0.9,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Modifiable cardiovascular risk factors in children at risk of acute myocardial infarction: A comprehensive review","authors":"M. Morales-Suárez-Varela ,&nbsp;C. Torrijo Belanche ,&nbsp;M. Saez ,&nbsp;I. Peraita-Costa ,&nbsp;A. Llopis-González","doi":"10.1016/j.semerg.2024.102341","DOIUrl":"10.1016/j.semerg.2024.102341","url":null,"abstract":"<div><div>While acute myocardial infarction is rare in children, a part of the pediatric population is at a higher risk due to preexisting non-modifiable conditions. To mitigate the risk, modifiable risk factors such as unhealthy diet or sedentary lifestyle should be controlled from childhood, promoting healthy habits from the earliest stages. The primary purpose of this review is to assess the evidence on lifestyle/nutrition related modifiable risk factor intervention on the risk of acute myocardial infarction in children found in four databases, PubMed, Embase, Scopus and WoS. After screening, 29 of 272 articles assessed met the inclusion criteria. We found evidence that a healthy lifestyle, including an adequate dietary pattern and good eating habits in childhood, reduces the prevalence of acute myocardial infarction. The data retrieved from this review are consistent with the hypothesis that a healthy lifestyle might contribute lower the risk of acute myocardial infarction in at-risk children.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102341"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intervención médico-farmacéutica sobre pacientes expuestos a la interacción azatioprina-alopurinol en la Comunidad de Madrid","authors":"J.M. Pinar Manzanet ,&nbsp;J.M. Izquierdo Palomares ,&nbsp;E. Prieto Utiel ,&nbsp;L. Escudero Crujera ,&nbsp;M.E. Trillo Gallo ,&nbsp;I. Santaolalla García ,&nbsp;A. Blázquez Valerón ,&nbsp;B.M. Escudero Vilaplana ,&nbsp;A.I. Villimar Rodríguez ,&nbsp;M. Cortijo Caballero ,&nbsp;Á. Mataix Sanjuan ,&nbsp;J.M. San Román Montero","doi":"10.1016/j.semerg.2024.102395","DOIUrl":"10.1016/j.semerg.2024.102395","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the impact of a medical-pharmaceutical intervention strategy on patients exposed to azathioprine-allopurinol (AZA-ALO) interaction in the Community of Madrid (CM).</div></div><div><h3>Material/methods</h3><div>Multicentre retrospective observational study. We reviewed the database generated after an intervention carried out in the healthcare context in which Primary Care Pharmacists (PCP) review the treatment of patients with safety risks and, when there are incidents, they contact (by telephone and/or e-mail) their Family Physicians (FP) for possible resolution.</div></div><div><h3>Study population</h3><div>CM patients with an active clinical history in Primary Care who have been dispensed both medications (AZA-ALO) in the period April-June 2022 according to prescription billing data from the National Health System (NHS).</div><div>Main variable: suppression or dose adjustment of either of the two drugs.</div></div><div><h3>Results</h3><div>Forty-nine patients were analysed. Mean age: 65.65<!--> <!-->±<!--> <!-->11.67 years. Males; 77.6%. 8,834 patients withdrew azathioprine (28,724 packs) and 89,297 withdrew allopurinol (141,188 packs) from pharmacies, with a very low prevalence of patients at risk (&lt;1%).</div><div>The prescription was modified in 32 patients (65.31%-IC95%: 51.98%-78.63%), with allopurinol being discontinued in 65.62% and, with regard to azathioprine, the dose was reduced by 18.75% and discontinued in 9.37%.</div><div>Analytical alterations compatible with adverse effects due to the interaction were recorded in 28 patients (57.1%-IC95%: 43.29%-71%), including anaemia (39.3%) and leukopenia/neutropenia (25%).</div></div><div><h3>Conclusions</h3><div>Coordinated intervention between pharmacists and physicians was effective, resulting in prescription modification in a significant percentage of patients, which reduced the risk of toxicity.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102395"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resiliencia en niños con cáncer: un recurso para su salud mental","authors":"Mónica Regalado Chamorro ,&nbsp;Aldo Medina Gamero","doi":"10.1016/j.semerg.2024.102401","DOIUrl":"10.1016/j.semerg.2024.102401","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102401"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factores determinantes de la vacunación antigripal en mayores de 65 años: una revisión sistemática","authors":"F.M. Escandell Rico ,&nbsp;L. Pérez Fernández","doi":"10.1016/j.semerg.2024.102391","DOIUrl":"10.1016/j.semerg.2024.102391","url":null,"abstract":"<div><div>Low influenza vaccination rates among specific risk groups contribute to the burden of disease and remain a major public health challenge. Therefore, the purpose of this review was to provide the most recent evidence on the determinants of influenza vaccination in people over 65<!--> <!-->years of age. During the review process, we followed the recommendations for PRISMA systematic reviews. The bibliographic search was carried out in databases Cumulative Index to Nursing and Allied Health Literature (CINAHL), SCOPUS, MedLine / PubMed, Cochrane, Google Scholar, with free and controlled language and the search terms MeSh: Vaccination Coverage, Health Communication, Aged, Influenza Vaccines by combining them with the Boolean operators AND and OR. The search was limited to articles published between 2019-2024. Seven original research articles were included, of which observational and cross-sectional studies were identified as the main type of study. The topic of study represents education, the recruitment of the vulnerable population and the detection of sociodemographic factors that affect vaccination coverage. The findings of this review suggest that it would be beneficial to take into account communication, education and recruitment as determining factors of influenza vaccination in those over 65<!--> <!-->years of age. In this sense, effective strategies could be implemented to increase vaccination coverage in the most vulnerable population and improve future vaccination campaigns.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102391"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percepción y conocimiento de la enfermedad hemorroidal en los profesionales sanitarios en España","authors":"M. Frías Vargas ,&nbsp;N. Fontanillas Gamilla ,&nbsp;I. Rivera Panizo ,&nbsp;D. Fuertes Domínguez ,&nbsp;C. Granja Ortega ,&nbsp;J.F. Peiró Morant ,&nbsp;en nombre del Grupo de Trabajo de Vasculopatías y de Aparato Digestivo de SEMERGEN","doi":"10.1016/j.semerg.2024.102393","DOIUrl":"10.1016/j.semerg.2024.102393","url":null,"abstract":"<div><h3>Introduction</h3><div>Hemorrhoidal disease (HD) is a public health problem in our clinics and in the quality of life of patients, therefore it is necessary to analyze the actions in the management of HD by healthcare professionals in Spain.</div></div><div><h3>Material and methods</h3><div>Observational, descriptive and cross-sectional study with data collection through a 28-question survey using a Google® form. 240 surveys were received. Quantitative variables were represented with means and standard deviation and qualitative variables with percentages.</div></div><div><h3>Results</h3><div>Two hundred and forty surveys were analyzed. Sixty-five percent of respondents were women, with a mean age of 48<!--> <!-->±<!--> <!-->12<!--> <!-->years. Ninety-three percent of the professionals had 21-30<!--> <!-->years of clinical experience, with more than 70% being family physicians. Fifty-nine percent considered that HD is adequately diagnosed in primary care, but there was a negative impact on follow-up during the COVID-19 pandemic, as 90% considered it inadequate. Forty-two percent of participants were not familiar with the Goligher classification, while 20% knew it and used it in their practice. The most commonly prescribed combination was the use of topical corticosteroids, bulk-forming laxatives, phlebotonics or venoactive drugs, and non-pharmacological measures (12.1%), with diosmin/hesperidin being the most prescribed venoactive agent (63%). Thirty-nine point six percent stated that HD is undertreated. Eighty-nine percent of physicians acknowledged not using any algorithm or protocol for the diagnosis, treatment, and follow-up of HD in their practice, and 89% stated that they were not trained in their workplaces. Seventy-five percent of doctors believed that one of the main limitations hindering the follow-up of the disease was the lack of time during consultations.</div></div><div><h3>Conclusions</h3><div>Approximately 3 out of 5 professionals believe they adequately manage HD, and only 1 out of 5 respondents acknowledge knowing and using the Goligher classification in their clinical practice. Furthermore, 2 out of 5 assert that HD is undertreated in primary care. The prescription patterns for HD are heterogeneous, involving multiple combinations. The vast majority of professionals do not follow any established protocol for managing the disease. The survey highlights the need for training our professionals in the diagnosis, treatment, and follow-up of HD to ensure that our patients receive the highest possible quality of healthcare.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102393"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estudio demográfico y de prevalencia del parkinsonismo en la región de Murcia","authors":"A. García Tévar,&nbsp;M.T. Herrero Ezquerro","doi":"10.1016/j.semerg.2024.102388","DOIUrl":"10.1016/j.semerg.2024.102388","url":null,"abstract":"<div><h3>Objectives</h3><div>To quantify parkinsonian patients in the Region of Murcia (RM), their health areas and zones, and find their prevalences and percentages.</div></div><div><h3>Material and methods</h3><div>All RM patients registered in Primary Care of the Murcian Health Service with the CIAP-2 code N87 were included. We calculated number, prevalence and percentages by age and sex groups, means and age ranges and years of evolution. The study was carried out at the age of diagnosis and at the age of data collection, analyzing their differences.</div></div><div><h3>Results</h3><div>We obtained 3050 parkinsonian patients (1476 men and 1574 women) with respective prevalences of 206.09 cases per 100,000 inhabitants (206.09/10⁵), 199.06/10⁵ and 213.15/10⁵, not significant differences by sex or in number of patients (p<!--> <!-->=<!--> <!-->0.79) or in prevalence (<em>P</em> <!-->=<!--> <!-->.52). By age group, prevalences were higher in men (<em>P</em> <!-->&lt;<!--> <!-->.05) between 50 and 99<!--> <!-->years of age (not between 90 and 94 and ≥<!--> <!-->100<!--> <!-->years). Of the 9 Health Areas, the highest prevalences were in areas IV<!--> <!-->Northwest, with 322.31/10⁵, and V<!--> <!-->Altiplano, with 304.30/10⁵, and the lowest prevalence, of 171.13/10⁵, was observed in Area VII<!--> <!-->Murcia East (<em>P</em> <!-->&lt;<!--> <!-->.05). Of the 85 Health Zones, the one with the highest prevalence was Lorca-La Paca, with 510.51/10⁵, and the one with the lowest Murcia-Zarandona, with 78.48/10⁵ (<em>P</em> <!-->&lt;<!--> <!-->.05).</div></div><div><h3>Conclusions</h3><div>First demographic and detailed prevalence study of parkinsonism in the RM. The prevalence in RM was 206.09/10⁵. By health areas, the highest prevalences were in the Northwest and Altiplano and by health areas a prevalence of 510.51/10⁵ stood out. This work aims to be useful to facilitate resource planning, with consequent better health care.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102388"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The quality and reporting of recommendation documents to enhance the integrity of clinical trials: A systematic review and critical appraisal","authors":"F.A. Butt ,&nbsp;M. Nunez-Nunez ,&nbsp;B. Juhász ,&nbsp;A. Bueno-Cavanillas ,&nbsp;K.S. Khan","doi":"10.1016/j.semerg.2024.102333","DOIUrl":"10.1016/j.semerg.2024.102333","url":null,"abstract":"<div><h3>Background</h3><div>Randomised clinical trials (RCTs) hold the highest validity level in effectiveness research. However, there is a growing concern regarding their trustworthiness. We aimed to appraise the quality and reporting of recommendation documents regarding research integrity to describe their contribution towards fostering RCT integrity.</div></div><div><h3>Methods</h3><div>Following prospective registration (<span><span>https://doi.org/10.17605/OSF.IO/DN93K</span><svg><path></path></svg></span>), searches of electronic databases (Scopus, PubMed, Google Scholar) and relevant websites were performed from inception to 30 July 2023 without language limitations. Data extraction and document appraisal using adapted versions of AGREE II, RIGHT and ACCORD checklists were carried out in duplicate. Appraisal data were synthesised as % of the maximum score and documents were classified as: good<!--> <!-->≥<!--> <!-->70%, average 50–69%, and poor<!--> <!-->&lt;<!--> <!-->50%.</div></div><div><h3>Results</h3><div>From 1310 citations 14 recommendation documents were selected. Of these, 11 documents (78%) were of poor quality according to all three appraisal checklists. Reviewer agreement was 86–100% regarding the checklist items. The top three documents were: “<em>International multi-stakeholder consensus statement on clinical trial integrity</em>” (score 70% on AGREE II, 96% on RIGHT and 88% on ACCORD); “<em>Development of consensus on essential virtues for ethics and research integrity</em>” (score 51% on AGREE II, 71% on RIGHT and 77% on ACCORD); and “<em>Hong Kong principles for assessing researchers</em>” (score 19% on AGREE II, 57% on RIGHT and 10% on ACCORD).</div></div><div><h3>Conclusion</h3><div>There is a room from improvement in the quality and reporting of recommendation documents to help fostering RCT integrity. All stakeholders in the RCT lifecycle making concerted efforts to improve trust in evidence-based medicine need robust guidance to underpin research integrity policies and guidelines.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102333"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guía ESC 2023 sobre el manejo de la enfermedad cardiovascular en pacientes con diabetes: lagunas en las categorías de riesgo cardiovascular","authors":"S. Torres-Conde ,&nbsp;F. Buitrago-Ramírez","doi":"10.1016/j.semerg.2024.102402","DOIUrl":"10.1016/j.semerg.2024.102402","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102402"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Escombroidosis. Un diagnóstico a considerar","authors":"A. Medina-Cobos ,&nbsp;A. Cabrerizo-Carvajal ,&nbsp;R. Ruiz-Villaverde","doi":"10.1016/j.semerg.2024.102352","DOIUrl":"10.1016/j.semerg.2024.102352","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102352"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}